Midori N. Torpoco-Rivera Profile
Midori N. Torpoco-Rivera

@Mndrtr

Followers
138
Following
459
Statuses
233

PGY-2 Internal Medicine / Peruvian M.D. 🇵🇪

Pennsylvania, USA
Joined August 2020
Don't wanna be here? Send us removal request.
@Mndrtr
Midori N. Torpoco-Rivera
11 hours
Deeply grateful to @GavHick for all the support and invaluable mentorship! Honored to have presented 'Impact of prior Heart Failure Hospitalization on Long-Term Outcomes following in ICD implantation and Generator Exchange' at #THT2025 #Cardiology #HeartFailure 🫀
@GavHick
Gavin Hickey
11 hours
@Mndrtr moderated abstract on relationship of HF hospitalizations and ICD placement/gen change. Pts with recent HF episodes within 3 months had overall worse outcomes- Thought provoking! #THT2025 @HviUpmc @PittCardiology
Tweet media one
Tweet media two
0
0
6
@Mndrtr
Midori N. Torpoco-Rivera
4 months
HFSA24 is done, but what exciting learning!! Thrilled about the promising outcomes of myosin inhibitors for #HFpEF Grateful to have presented two projects: a case on cardiogenic shock in sarcoidosis and my QI project on a novel heart failure order set. #CardioTwitter #HFSA2024🫀
Tweet media one
Tweet media two
Tweet media three
0
1
6
@Mndrtr
Midori N. Torpoco-Rivera
5 months
Attending the Western Pennsylvania Cardiogenic 🫀Shock Symposium for the second time, learning from top leaders in the field and witnessing the inspiring camaraderie that brings everyone together. @GavHick @manreetkanwar
Tweet media one
Tweet media two
Tweet media three
0
1
7
@Mndrtr
Midori N. Torpoco-Rivera
6 months
RT @GavHick: At the #PittsburghHeartSummit. Thanks to Andy Kiser and Chris Pray from St Clair Hospital for hosting us. Lots of abstracts/po…
0
7
0
@Mndrtr
Midori N. Torpoco-Rivera
10 months
0
0
0
@Mndrtr
Midori N. Torpoco-Rivera
10 months
RT @eddyjoemd: As a trainee, deciding who was appropriate for ICU admit was a skill that needed to be learned/honed. Every now and then, th…
0
60
0
@Mndrtr
Midori N. Torpoco-Rivera
11 months
RT @MHBeasleyMD: Here is our schedule of talks for the rest of the academic year. If you are interested in participating in the AHFTC Lectu…
0
7
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @eddyjoemd: The truth is that you’ll never actually “make it”. Once you hit your goal you’ll immediately formulate another one. The driv…
0
52
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @MHBeasleyMD: 🚨 Attention! We are launching our Advanced Heart Failure and Transplant Cardiology fellow lecture series this week! 30-…
0
12
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @CircAHA: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation #AHAJournals
0
169
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @cliffreid: WTF is a ‘difficult airway’? A 🧵 1/14
0
110
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @ACCinTouch: The goal of the ADVOR trial was to compare incidence of successful decongestion among patients w/ acute decompensated heart…
0
8
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @PennMedicine: POV: Telling your parents you just won the @NobelPrize... @WeissmanLab
0
605
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
@NatalyecheMD You rock!!!
0
0
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
Happy #NationalLatinoPhysicianDay! So proud to be Latina! so proud to be Peruvian 🇵🇪! Glad to be part of this 6% of Latinx physicians, but 6% is not enough when 19% of the US population identifies as Latinx and 70% speak Spanish at home Representation matters!💪
0
4
32
@Mndrtr
Midori N. Torpoco-Rivera
1 year
@NatalyecheMD Buenaaaaaa!!! Rooting for you Naty!!!
0
0
1
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @DrAkhilRaghavan: 💥AMIODARONE is a class III antiarrhythmic drug which is widely used in ER for treating arrhythmias. A 🧵 on situations…
0
492
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @Dr_Oubre: Residents are telling me they're still being taught old billing rules. Reminder, since Jan 1, 2023: 🔶 HPI has no strict bill…
0
228
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
RT @PulmCrit: introducing the IBPH (internet book of hospital pulm) expansion to the IBCC section on pulm, with a goal of covering inpatie…
0
117
0
@Mndrtr
Midori N. Torpoco-Rivera
1 year
😍🫀
@CardiacTrials
Cardiac Trials
1 year
~~#ESC2023~~ Catheter ablation in end-stage heart failure? A population not previously studied in this context, having been excluded from prior large trials. This trial shows the importance of sinus rhythm maintenance in this vulnerable population. CASTLE-HTx Trial, NEJM 2023 ♥️
Tweet media one
Tweet media two
0
0
6